Literature DB >> 6132291

Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.

J Harenberg, R Zimmermann, F Schwarz, W Kübler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132291     DOI: 10.1016/s0140-6736(83)92107-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Anticoagulants.

Authors:  M de Swiet
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14

2.  Danaparoid reduces the incidence of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Authors:  S Machida; M Onizuka; M Toyosaki; Y Aoyama; H Kawai; J Amaki; R Hara; A Ichiki; Y Ogawa; H Kawada; K Ando
Journal:  Bone Marrow Transplant       Date:  2016-11-28       Impact factor: 5.483

3.  Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.

Authors:  J C Stiekema; H P Wijnand; T G Van Dinther; H C Moelker; J Dawes; A Vinchenzo; H Toeberich
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

4.  [Ambulatory long-term prevention of thromboembolism with low-molecular weight heparin].

Authors:  J Harenberg; G Leber; J Augustin; R Raedsch; F Schwarz; A Stiehl; R Zimmermann
Journal:  Klin Wochenschr       Date:  1987-04-01

5.  Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function.

Authors:  D P Mikhailidis; M A Barradas; A M Mikhailidis; H Magnani; P Dandona
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

Review 6.  Heparin-induced thrombocytopenia.

Authors:  B H Chong; M C Berndt
Journal:  Blut       Date:  1989-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.